The use of medication against attention deficit hyperactivity disorder in Denmark: A drug use study from a national perspective

European Journal of Clinical Pharmacology

Volumn 68, Issue 10, 2012, Pages 1443-1450

  Pottegård, Anton ^a,b   Bjerregaard, Bine Kjøller ^b   Glintborg, Dorte ^b   Hallas, Jesper ^a   Moreno, Søren Ilsøe ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b DANISH MEDICINES AGENCY   (Denmark)

Author keywords

ADHD; Atomoxetine; Denmark; Drug utilization; Methylphenidate; Psychostimulants

Indexed keywords

ATOMOXETINE; METHYLPHENIDATE; MODAFINIL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; DENMARK; DISEASE REGISTRY; DRUG MONITORING; DRUG USE; DRUG UTILIZATION; FEMALE; GENERAL PRACTITIONER; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INFANT; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY ANALYSIS; TREATMENT DURATION;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; DENMARK; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; METHYLPHENIDATE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; PREVALENCE; YOUNG ADULT;

EID: 84866598707     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-012-1265-y     Document Type: Article

References (21)

1. Polanczyk G, Rohde LA (2007) Epidemiology of attention-deficit/ hyperactivity disorder across the lifespan. Curr Opin Psychiatry 20 (4):386-92
2. Fayyad J, De GR, Kessler R, Alonso J, Angermeyer M, Demyttenaere K et al (2007) Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402-9
3. Danish National Board of Health. [Guide to medicamental treatment of children and adolescents with psychiatric disorders] [https://www retsinformation dk/Forms/R0710 aspx?id0114817]; Last updated: 12-10-2010].
4. Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC (2011) et al. ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults, N Engl J Med
5. Smith G, Jongeling B, Hartman P (2010) RUssell C, Landou L. Long-term outcomes associated with stimulation medication in the treatment of ADHD in children. Government of Western Australia; Published in, Raine ADHD Study
6. Gillberg C,Melander H, von Knorring AL, Janols LO, Thernlund G, Hagglof B et al (1997) Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 54 (9):857-64
7. Hoza B, Gerdes AC,Mrug S, Hinshaw SP, BukowskiWM, Gold JA et al (2005) Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder. J Clin Child Adolesc Psychol 34(1):74-86
8. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up (2004) 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics 113 (4):754-61
9. Breggin PR (2001) MTA Study has flaws. Arch Gen Psychiatry 58 (12):1184-7
10. Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R et al (2008) Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 47(1):21-31
11. Kildemoes HW, Sorensen HT, Hallas J (2011) The Danish National Prescription Registry. Scand J Public Health 39(7 Suppl):38-41
12. Hallas J, Stovring H (2006) Templates for analysis of individuallevel prescription data. Basic Clin Pharmacol Toxicol 98(3):260-5
13. Ohayon MM, Priest RG, Zulley J, Smirne S, Paiva T (2002) Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology 58(12):1826-33
14. Zuvekas SH, Vitiello B, Norquist GS (2006) Recent trends in stimulant medication use among U.S. children. Am J Psychiatry 163(4):579-85
15. Trip AM, Visser ST, Kalverdijk LJ, de Jong-van den Berg LT (2009) Large increase of the use of psycho-stimulants among youth in the Netherlands between 1996 and 2006. Br J Clin Pharmacol 67(4):466-8
16. Schubert I, Koster I, Lehmkuhl G (2010) The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007. Dtsch Arztebl Int 107(36):615-21
17. Zoega H, Furu K, Halldorsson M, Thomsen PH, Sourander A, Martikainen JE (2011) Use of ADHD drugs in the Nordic countries: a population-based comparison study. Acta Psychiatr Scand 123(5):360-7
18. Rosler M, Casas M, Konofal E, Buitelaar J (2010) Attention deficit hyperactivity disorder in adults.World J Biol Psychiatry 11(5):684-98
19. Pedersen E. [ADHD among adults - a life in frustration and chaos]. Månedsskrift for Almen Praksis 2008;May 86(5):537.
20. Asheim H, Nilsen KB, Johansen K, Furu K (2007) Prescribing of stimulants for ADHD in Nordland County. Tidsskr Nor Laegeforen 127(18):2360-2
21. Zoega H, Baldursson G, Halldorsson M (2007) Use of methylphenidate among children in Iceland 1989-2006. Laeknabladid 93 (12):825-32